Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03204708
Other study ID # 88931902-604.01.01
Secondary ID
Status Completed
Phase N/A
First received May 22, 2017
Last updated February 12, 2018
Start date April 15, 2016
Est. completion date February 28, 2017

Study information

Verified date February 2018
Source Istanbul University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

patients undergoing modified radical mastectomy were divided into two groups. patients in catheter group were placed a catheter with open technique by the surgeon in the pectoral area. thirty minutes before extubation %1 lidocain 10 ml, %0.5 bupivacain 10 ml and 10 ml %0.9 sodium chloride were given through the catheter for postoperative analgesia. patients in iv analgesia group were given 100 mg tramadol iv 30 minutes before extubation. visual analog pain scale (VAS) scores, rescue analgesic requirement, complications were recorded and compared between two groups 1, 6, 12, 24 hours and 90 days after surgery.


Description:

patients undergoing modified radical mastectomy were divided into two groups by computer. patients in catheter group were placed a catheter under clavipectoral fascia in the neighbourhood of nervus thoracicus longus, nervus thoracodorsalis, nervus pectoralis lateralis, nervus pectoralis medialis at the 1/3 lateral part of clavicula. solution included 10 ml of %0.5 bupivacain, %1 lidocain, 10 ml %0.9 sodium chloride totally 30 ml were given via the catheter for postoperative analgesia at the end of surgery. patients in iv analgesia group were given 100 mg tramadol iv 30 minutes before extubation. Patients in both groups were given dexketoprofen 50 mg iv if the VAS score was over 4. VAS scores, rescue analgesic requirement and timing, complications were recorded and compared between groups 1, 6, 12, 24 hours and 90 days after surgery.


Recruitment information / eligibility

Status Completed
Enrollment 86
Est. completion date February 28, 2017
Est. primary completion date February 15, 2017
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- American Society of Americans Class I-II

Exclusion Criteria:

- male

- allergy to local anesthetics or

- anticoagulant drug use

- central or peripheric nerve disease

- pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Device:
catheter
catheter was placed under clavipectoral fascia by open technique by surgeon at the 1/3 lateral part of clavicula neighbourhood of nervus thoracicus longus, nervus thoracodorsalis, nervus pectoralis lateralis, nervus pectoralis medialis
Drug:
iv analgesia
patients were given 100 ml of tramadol 30 minutes before extubation

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Istanbul University

Outcome

Type Measure Description Time frame Safety issue
Other rescue analgesic requirement patients whose VAS scores were over 4 were given 50 mg of dexketoprofen in Group I, 10 ml %0.25 bupivacain in Group II 1, 6, 12 and 24 hours after operation
Primary VAS scores patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain. 1 hour after operation
Primary VAS scores patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain. 6 hours after operation
Primary VAS scores patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain. 12 hours after operation
Primary VAS scores patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain. 24 hours after operation
Secondary VAS scores patients were asked to give a point between 0 to 10 for their pain level. 0 is no pain, 10 is the strongest pain. 3 months after operation
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT03022864 - Accurate Diagnosis System for Postoperative Chronic Pain Based on fMRI N/A
Completed NCT06143020 - Effect of ESPB on Postoperative Pain in Patients With Breast Cancer Implant Reconstruction N/A
Recruiting NCT02905916 - The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy Phase 4
Not yet recruiting NCT04301375 - Omission of Surgery and Sentinel Lymph Node Dissection in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti- HER2-based Neoadjuvant Therapy (ELPIS Trial) Phase 2
Completed NCT05408676 - Comparison of Dexamethasone Alone vs in Combination With Pericardium 6 (P6) Electrical Stimulation or Granisetron in the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Breast Cancer Surgery N/A
Active, not recruiting NCT05364450 - Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors N/A
Recruiting NCT04948983 - The Effect of a Patient Decision Aids for Breast Cancer Screening N/A
Not yet recruiting NCT06251544 - TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer Phase 1
Not yet recruiting NCT06268665 - Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy Phase 2
Recruiting NCT04489992 - Experiment on the Use of Innovative Computer Vision Technologies for Analysis of Medical Images in the Moscow Healthcare System
Completed NCT02611544 - Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer Survivors N/A
Completed NCT05299021 - Serratus Anterior Plane Block for Modified Radical Mastectomy: Double-point VS Single-point N/A